TCRT - Alaunos Therapeutics, Inc.
Previous close
1.74
0.040 2.299%
Share volume: 21,765
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$1.70
0.04
0.02%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-15 | 2024-08-14 | 2024-11-14 | |
| Assets | ||||
| Total Assets | 6.037 M | 4.678 M | 3.550 M | |
| Current Assets | 6.037 M | 4.678 M | 3.550 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.145 M | 2.463 M | 1.683 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 6.037 M | 4.678 M | 3.550 M | |
| Total liabilities | 1.240 M | 907.000 K | 826.000 K | |
| Total current liabilities | 1.240 M | 907.000 K | 826.000 K | |
| Accounts Payable | 597.000 K | 365.000 K | 458.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.797 M | 3.771 M | 2.724 M | |
| Common stock | 922.246 M | 922.348 M | 922.428 M | |
| Retained earnings | -917.449 M | -918.577 M | -919.704 M |